Moreover, sFRP4 expression is positively correlated with the NAFLD activity score, elevated HbA1c level and insulin resistance, and reduced GSIS, suggesting that elevated SFRP4 is a valuable biomarker of β‐cell dysfunction, insulin resistance and T2DM.139, 140, 141. Here, SFRP4 is linked to metabolic dysfunction-associated steatotic liver disease.